Anti-S6K antibody produced in rabbit
SIGMA/SAB4502691 - affinity isolated antibody
Synonym: 70 kDa ribosomal protein S6 kinase 1; Ribosomal protein S6 kinase I; S6K; S6K1; p70 S6 kinase α
Product Type: Chemical
Immunohistochemistry Anti-S6K: Cat. No. SAB4502691: Immunohistochemistry analysis of paraffin-embedded human breast carcinoma tissue using Anti-S6K antibody. Cells on the left were treated with the Anti-S6K antibody. Cells on the right (negative control) were treated with both Anti-S6K antibody and the synthesized immunogen peptide.
Western Blotting Anti-S6K: Cat. No. SAB4502691: Immunoblotting analysis of extracts from COLO205/Jurkat cells, using Anti-S6K antibody. The lane on the left was treated with the Anti-S6K antibody. The lane on the right (negative control) was treated with both Anti-S6K antibody and the synthesized immunogen peptide.
| antibody form | affinity isolated antibody |
| antibody product type | primary antibodies |
| biological source | rabbit |
| clone | polyclonal |
| concentration | ~1 mg/mL |
| conjugate | unconjugated |
| form | buffered aqueous solution |
| mol wt | antigen 59 kDa |
| NCBI accession no. | P23443   |
| Quality Level | 100 |
| shipped in | wet ice |
| species reactivity | rat, human, mouse |
| storage temp. | −20°C |
| target post-translational modification | unmodified |
| technique(s) | ELISA: 1:5000 |
| immunohistochemistry: 1:50-1:100 | |
| western blot: 1:500-1:1000 | |
| UniProt accession no. | P23443 |
| Biochem/physiol Actions: | Ribosomal protein S6 kinase B1 (RPS6KB1), or S6K1, regulates cell size and progression through cell cycle. It also inhibits pro-apoptotic protein bcl-2-associated death promoter (BAD) and promotes cell survival. mTORC1 (mammalian TORC1) phosphorylates and activates S6K1, mTORC1-S6K1 complex regulates various cellular processes, such as transcription, translation, protein and lipid synthesis, cell growth/size and cell metabolism. Overexpression of S6 kinase 1 (S6K1) leads to many disorders , including diabetes, aging, and cancer. Development of organometallic S6K1 inhibitors such as EM5 and FL772, might be a potential method for the treatment of diseases caused by aberrant activity of S6K1. The increased expression of S6K1 in obesity results in adipose tissue dysfunction via a close association with insulin resistance and inflammation development. Elevated expression of S6K1 is observed in breast cancer patients. |
| Disclaimer: | Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals. |
| Features and Benefits: | Evaluate our antibodies with complete peace of mind. If the antibody does not perform in your application, we will issue a full credit or replacement antibody. Learn more. |
| General description: | Ribosomal protein S6 kinase B1 (RPS6KB1) also known as S6Ka or S6K1 is an isoform of S6 kinases, which belong to AGC serine/threonine kinases of the ribosomal S6 kinase (RSK) family. S6K1 is encoded by the gene mapped to human chromosome 17q23. S6K1 is activated on phosphorylation of its domains, which include T-loop and hydrophobic motif and Ser-Pro/Thr-Pro residues at C- terminal. |
| Immunogen: | The antiserum was produced against synthesized peptide derived from human S6K. Immunogen Range: 261-310 |
| Physical form: | Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
| RIDADR | NONH for all modes of transport |
| WGK Germany | nwg |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Storage Temp. | −20°C |
| UNSPSC | 12352203 |